First National Bank of Omaha’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-35,445
Closed -$1.46M 327
2023
Q2
$1.46M Buy
35,445
+191
+0.5% +$7.86K 0.08% 205
2023
Q1
$2.02M Sell
35,254
-487
-1% -$28K 0.12% 175
2022
Q4
$2M Sell
35,741
-508
-1% -$28.5K 0.12% 176
2022
Q3
$1.54M Buy
36,249
+174
+0.5% +$7.37K 0.1% 197
2022
Q2
$1.95M Sell
36,075
-530
-1% -$28.6K 0.12% 170
2022
Q1
$2.35M Sell
36,605
-15,303
-29% -$983K 0.12% 174
2021
Q4
$3.48M Buy
51,908
+1,484
+3% +$99.4K 0.17% 150
2021
Q3
$3.45M Sell
50,424
-3,679
-7% -$252K 0.18% 149
2021
Q2
$3.74M Hold
54,103
0.2% 148
2021
Q1
$3.74M Sell
54,103
-3,793
-7% -$262K 0.2% 148
2020
Q4
$3.76M Buy
57,896
+5,768
+11% +$374K 0.2% 141
2020
Q3
$2.46M Sell
52,128
-71
-0.1% -$3.35K 0.15% 147
2020
Q2
$2.45M Sell
52,199
-422
-0.8% -$19.8K 0.16% 142
2020
Q1
$2.35M Buy
52,621
+7,191
+16% +$321K 0.18% 140
2019
Q4
$2.65M Buy
45,430
+3,675
+9% +$214K 0.16% 156
2019
Q3
$2.51M Buy
41,755
+711
+2% +$42.7K 0.16% 160
2019
Q2
$2.29M Buy
41,044
+1,001
+2% +$55.9K 0.15% 165
2019
Q1
$2.23M Buy
40,043
+4,424
+12% +$246K 0.15% 157
2018
Q4
$1.61M Sell
35,619
-4,361
-11% -$197K 0.12% 171
2018
Q3
$2.63M Buy
39,980
+1,076
+3% +$70.9K 0.15% 182
2018
Q2
$2.51M Sell
38,904
-152
-0.4% -$9.79K 0.15% 185
2018
Q1
$2.16M Buy
39,056
+1,339
+4% +$74.1K 0.13% 194
2017
Q4
$1.81M Buy
37,717
+5,065
+16% +$242K 0.11% 219
2017
Q3
$1.65M Buy
32,652
+585
+2% +$29.5K 0.1% 219
2017
Q2
$1.75M Sell
32,067
-6,420
-17% -$350K 0.11% 210
2017
Q1
$1.62M Buy
38,487
+8,255
+27% +$348K 0.1% 222
2016
Q4
$1.3M Buy
30,232
+1,192
+4% +$51.1K 0.08% 233
2016
Q3
$1.2M Buy
29,040
+3,390
+13% +$140K 0.09% 176
2016
Q2
$1.02M Sell
25,650
-150
-0.6% -$5.98K 0.08% 182
2016
Q1
$869K Buy
25,800
+1,700
+7% +$57.3K 0.06% 195
2015
Q4
$817 Sell
24,100
-950
-4% -$32 0.06% 206
2015
Q3
$746 Sell
25,050
-1,127
-4% -$34 0.06% 219
2015
Q2
$629 Hold
26,177
0.04% 248
2015
Q1
$629 Buy
26,177
+856
+3% +$21 0.04% 248
2014
Q4
$561K Buy
+25,321
New +$561K 0.04% 281